1. Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Issue 1 (January 2021) Authors: Heaney, Liam G; Busby, John; Hanratty, Catherine E; Djukanovic, Ratko; Woodcock, Ashley; Walker, Samantha M; Hardman, Timothy C; Arron, Joseph R; Choy, David F; Bradding, Peter; Brightling, Christopher E; Chaudhuri, Rekha; Cowan, Douglas C; Mansur, Adel H; Fowler, Stephen J; Niven, Robert M; Howa... Journal: Lancet Issue: Volume 9:Issue 1(2021) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗